Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Immunology and Allergy Clinics of North America|October 24, 2025
Real-world Experience with New Systemic Agents for Atopic Dermatitis in the NetherlandsAnne R Schlösser, A C M Lia Kunkeler, Dirk Jan Hijnen
Dermatitis : Contact, Atopic, Occupational, Drug|August 30, 2007
Cyclosporin A treatment is associated with increased serum immunoglobulin E levels in a subgroup of atopic dermatitis patientsDirk Jan Hijnen, Edward Knol, Carla Bruijnzeel-Koomen, et al.
Clinical and Experimental Dermatology|January 26, 2023
Tralokinumab treatment for patients with moderate-to-severe atopic dermatitis in daily practiceAnne R Schlösser, Madena Shareef, Jill Olydam, et al.
Frontiers in Medicine|April 21, 2023
Reducing scratching behavior in atopic dermatitis patients using the EMDR treatment protocol for urge: A pilot studyMathijs R de Veer, Rick Waalboer-Spuij, Dirk Jan Hijnen, et al.
The Journal of Dermatology|August 30, 2021
Care for children with atopic dermatitis in the Netherlands during the COVID-19 pandemic: Lessons from the first wave and implications for the futureAviël Ragamin, Linde E M de Wijs, Dirk-Jan Hijnen, et al.
Acta Dermato-Venereologica|August 12, 2025
Topical Steroid Withdrawal: Perspectives of Dutch Healthcare ProfessionalsFlorence Vroman, Charlotte S Schimmel, Lisa P Van der Rijst, et al.
The British Journal of Dermatology|November 13, 2025
From prebiotics to engineered microbes: microbe-inspired therapies for atopic dermatitisNoor E van Hout, Guillermo Nevot, Patrick A M Jansen, et al.
Blood|December 10, 2009
Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilizationJorg van Loosdregt, Yvonne Vercoulen, Teun Guichelaar, et al.
Patient Preference and Adherence|January 26, 2023
Impact of the First SARS-CoV-2 Lockdown on Adherence to Biological Treatment in Patients with Immune-Mediated Inflammatory Diseases in the NetherlandsRomy van der Groef, Pascal H P de Jong, Dirk Jan Hijnen, et al.
Trials|July 16, 2024
The UPDATE trial (UVB Phototherapy in Dermatology for ATopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczemaEva Knöps, Phyllis Spuls, Ruben Duijnhoven, et al.
Pageof 2